To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma.

Conditions:   Myelodysplastic Syndromes;   Multiple Myeloma;   Anemia Intervention:   Drug: INCB000928 Sponsor:   Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials